Health Catalyst (NASDAQ:HCAT) General Counsel Sells 70,000 Shares of Stock

Health Catalyst, Inc. (NASDAQ:HCAT) General Counsel Benjamin Landry sold 70,000 shares of Health Catalyst stock in a transaction that occurred on Wednesday, November 11th. The stock was sold at an average price of $1.43, for a total transaction of $100,100.00. Following the completion of the transaction, the general counsel directly owned 281,372 shares in the company, valued at approximately $402,361.96. The trade was a 19.92% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Benjamin Landry also recently made the following trade(s):

• On Thursday, November 12th, Benjamin Landry sold 29,478 shares of Health Catalyst stock. The stock was sold at an average price of $1.39, for a total transaction of $40,974.42.

Health Catalyst Stock Up 10.3%

Shares of NASDAQ HCAT traded up $0.14 during trading hours on Friday, hitting $1.50. 465,291 shares of the stock were exchanged, compared to its average volume of 920,868. Health Catalyst, Inc. has a 12 month low of $0.96 and a 12 month high of $3.02. The firm has a fifty day moving average price of $1.69 and a 200-day moving average price of $1.69. The company has a market cap of $114.22 million, a PE ratio of -0.53 and a beta of 1.52.

Health Catalyst (NASDAQ:HCAT) last announced its earnings results on Thursday, November 5th. The company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.05) by $0.02. Health Catalyst had a negative net margin of 74.24% and a negative return on equity of 4.84%. The company had revenue of $56.28 million during the quarter, compared to the consensus estimate of $55.39 million. As a group, equities analysts anticipate that Health Catalyst, Inc. will post -0.18 earnings per share for the current fiscal year.

Institutional Trading of Health Catalyst

Several large investors have recently bought and sold shares of the stock. Palogic Value Management L.P. acquired a new position in Health Catalyst during the 2nd quarter valued at approximately $9,796,000. BlackRock Inc. purchased a new position in Health Catalyst in the 2nd quarter worth $3,654,000. Hsbc Holdings PLC purchased a new position in Health Catalyst in the 2nd quarter worth $809,000. Squarepoint Ops LLC lifted its position in Health Catalyst by 1,214.8% during the 2nd quarter. Squarepoint Ops LLC now owns 400,210 shares of the company’s stock worth $796,000 after acquiring an additional 369,772 shares during the period. Finally, Renaissance Technologies LLC acquired a new stake in Health Catalyst during the 1st quarter worth about $276,000. Hedge funds and other institutional investors own 85.00% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Health Catalyst in a report on Monday, October 26th. Wells Fargo & Company lowered their price objective on Health Catalyst from $1.75 to $1.50 and set an “equal weight” rating for the company in a research report on Thursday, August 13th. Citigroup dropped their target price on Health Catalyst from $2.50 to $2.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 11th. Finally, Canaccord Genuity Group lowered Health Catalyst from a “buy” rating to a “hold” rating and reduced their target price for the company from $3.00 to $1.80 in a research report on Thursday, August 20th. Five equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus price target of $2.01.

About Health Catalyst

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its solutions are designed to help providers use clinical, operational, and financial data to support decision-making and improve care delivery. The company’s offerings include a data platform that brings together information from multiple sources, analytics applications for healthcare workflows, and professional services. These services can include implementation, data management, and support for organizations developing and applying analytics programs.